Britt Petty

Chief Man­u­fac­tur­ing Officer

Britt Petty is Chief Man­u­fac­tur­ing Officer at Kriya. He joined Kriya from AveXis, a Novartis company, focused on the development and com­mer­cial­iza­tion of gene therapies for neu­ro­log­i­cal genetic diseases, where he was the Chief Technical Officer (interim) and Head of Global Man­u­fac­tur­ing. At AveXis, Britt was responsible for man­u­fac­tur­ing the company’s commercial and clinical gene therapy products at both internal and external sites across the United States and Europe. He oversaw supply chain, engineering, program management, and man­u­fac­tur­ing science and technology functions. Prior to AveXis, Britt held senior man­u­fac­tur­ing roles at Biogen, including as the site head for the company’s North Carolina facility. He previously held man­u­fac­tur­ing roles of increasing respon­si­bil­i­ty at Amgen and Eli Lily and Co. Britt received his MBA from the University of North Carolina at Chapel Hill and his under­grad­u­ate degree in mechanical engineering at Rose-Hulman Institute of Technology.